OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - IMMUNIC INC ownership

IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 66 filers reported holding IMMUNIC INC in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of IMMUNIC INC
ValueSharesWeighting
Q3 2023$1,119,680
-43.7%
761,687
-3.8%
0.03%
-55.6%
Q2 2023$1,987,134
+94.4%
791,687
+15.4%
0.06%
+103.2%
Q1 2023$1,022,337
-99.8%
686,132
+246.6%
0.03%
+158.3%
Q3 2022$626,000,000
-22.4%
197,988
-14.9%
0.01%0.0%
Q2 2022$807,000,000232,5910.01%
Other shareholders
IMMUNIC INC shareholders Q2 2023
NameSharesValueWeighting ↓
Omega Fund Management, LLC 1,788,160$2,628,5952.41%
Gratus Capital, LLC 1,686,455$2,479,0890.17%
INNOVIS ASSET MANAGEMENT LLC 272,457$400,5120.15%
Parkman Healthcare Partners LLC 562,506$826,8840.15%
RTW INVESTMENTS, LP 4,335,255$6,372,8250.13%
Logos Global Management LP 421,184$619,1400.08%
Ikarian Capital, LLC 450,000$661,5010.08%
BVF INC/IL 1,149,425$1,689,6550.05%
Soleus Capital Management, L.P. 300,000$441,0000.04%
COWEN AND COMPANY, LLC 317,059$466,0760.03%
View complete list of IMMUNIC INC shareholders